Privia Health Group, Inc. (PRVA) Stock
4 of the hedge funds AlphaScala tracks reported PRVA in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Renaissance Technologies's at $16.28M.
Which hedge funds own PRVA?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Renaissance Technologies Jim Simons (founder) | 633K | $16.28M | -19% |
| D.E. Shaw David Shaw | 353K | $9.09M | +114% |
| Millennium Management Israel Englander | 268K | $6.90M | -62% |
| Citadel Ken Griffin | 49K | $1.26M | -90% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →PRVA price chart
Powered by TradingViewWhat does Privia Health Group, Inc. do?
Privia Health Group, Inc. is a technology-driven physician enablement company operating nationally in the United States. It collaborates with physician practices, health plans, and health systems to optimize workflows, enhance patient experiences, and support high-value care delivery in both in-person and virtual settings. The company provides a comprehensive platform of technology and population health tools that streamline providers' operations, reduce administrative burdens through management services organizations, and enable single-TIN medical groups for improved negotiating power, clinical integration, and aligned financial incentives. Privia Health also manages accountable care organizations under the Privia Quality Network, which engage patients, minimize inappropriate utilization, boost care coordination, and improve quality metrics to advance value-based care across Medicare, Medicare Advantage, commercial, and Medicaid programs. Its physician-led governance and cloud-based solutions empower primary care-centric networks, helping independent practices focus on clinical excellence while connecting with payers and new patient populations. Founded in 2007 and headquartered in Arlington, Virginia, Privia Health Group, Inc. plays a key role in transforming healthcare delivery toward better outcomes and efficiency in the healthcare sector.